Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-15 4:05 pm Purchase | 13D | Avenue Therapeutics, Inc. ATXI | Fortress Biotech Inc. FBIO | 180,425 8.900% | 132,904 (+279.68%) | View |
| 2024-11-14 3:22 pm Purchase | 13G | Avenue Therapeutics, Inc. ATXI | ARMISTICE CAPITAL LLC | 115,000 7.210% | 115,000 (New Position) | View |
| 2024-05-02 4:02 pm Sale | 13G | Avenue Therapeutics, Inc. ATXI | Davidow Robert L | 17,206 2.900% | -258 (-1.48%) | View |
| 2024-04-17 4:05 pm Purchase | 13D | Avenue Therapeutics, Inc. ATXI | Fortress Biotech Inc. FBIO | 47,521 8.000% | 33,533 (+239.74%) | View |
| 2024-01-02 3:45 pm Purchase | 13G | Avenue Therapeutics, Inc. ATXI | SABBY MANAGEMENT LLC | 8,814 11.000% | 5,294 (+150.40%) | View |
| 2023-12-13 4:03 pm Sale | 13G | Avenue Therapeutics, Inc. ATXI | Davidow Robert L | 17,464 9.890% | -8,227 (-32.02%) | View |
| 2023-11-28 4:05 pm Purchase | 13G | Avenue Therapeutics, Inc. ATXI | Davidow Robert L | 25,691 14.500% | 25,691 (New Position) | View |
| 2023-09-18 5:08 pm Purchase | 13D | Avenue Therapeutics, Inc. ATXI | Fortress Biotech Inc. FBIO | 13,987 12.100% | 6,278 (+81.43%) | View |
| 2023-02-14 11:22 am Sale | 13G | Avenue Therapeutics, Inc. ATXI | CVI Investments, Inc. | 3,347 4.900% | -289 (-7.95%) | View |
| 2023-01-06 4:31 pm Purchase | 13D | Avenue Therapeutics, Inc. ATXI | Fortress Biotech Inc. FBIO | 7,710 11.300% | 4,296 (+125.86%) | View |
| 2023-01-04 08:25 am Purchase | 13G | Avenue Therapeutics, Inc. ATXI | SABBY MANAGEMENT LLC | 3,520 11.000% | 3,520 (New Position) | View |
| 2022-12-14 4:06 pm Sale | 13G | Avenue Therapeutics, Inc. ATXI | Nantahala Capital Management LLC | 0 0.000% | -1,292 (Position Closed) | View |
| 2022-10-19 07:26 am Sale | 13D | Avenue Therapeutics, Inc. ATXI | InvaGen Pharmaceuticals Inc. | 0 0.000% | -9,476 (Position Closed) | View |
| 2022-10-17 12:01 pm Purchase | 13G | Avenue Therapeutics, Inc. ATXI | CVI Investments, Inc. | 3,636 6.600% | 3,636 (New Position) | View |
| 2022-10-17 06:01 am Purchase | 13G | Avenue Therapeutics, Inc. ATXI | Mitchell P. Kopin | 2,891 4.990% | 2,891 (New Position) | View |
| 2022-07-28 4:30 pm Purchase | 13D | Avenue Therapeutics, Inc. ATXI | InvaGen Pharmaceuticals Inc. | 9,476 46.950% | 533 (+5.96%) | View |
| 2022-02-14 08:31 am Purchase | 13G | Avenue Therapeutics, Inc. ATXI | Nantahala Capital Management LLC | 1,292 7.700% | 1,292 (New Position) | View |
| 2022-02-09 3:24 pm Sale | 13G | Avenue Therapeutics, Inc. ATXI | VANGUARD GROUP INC | 402 2.420% | -433 (-51.83%) | View |
| 2022-02-09 3:24 pm Sale | 13G | Avenue Therapeutics, Inc. ATXI | VANGUARD INDEX FUNDS | 402 2.420% | -343 (-46.04%) | View |
| 2021-02-12 5:20 pm Sale | 13G | Avenue Therapeutics, Inc. ATXI | Opaleye Management Inc. | 0 0.000% | -920 (Position Closed) | View |